EuroPCR 2026: A Week of Scientific Exchange and Collaboration
EuroPCR 2026 has come to an end after an intense week of scientific discussions, investigator meetings and international collaboration across the cardiovascular research community.
Throughout the congress, CERC was strongly represented in multiple scientific sessions covering coronary artery disease, structural heart interventions, renal denervation and clinical research innovation. Several CERC-related studies were featured during Hotline and Late Breaking Trial sessions, highlighting ongoing advances in interventional cardiology and patient care.
The congress also included numerous Investigator Meetings bringing together investigators, study coordinators, sponsors and partners from around the world to discuss study progress, recruitment, scientific strategy and future collaboration opportunities.
Beyond the scientific programme, many valuable exchanges also took place at Booth M11 throughout the week, strengthening existing collaborations and creating new connections within the international cardiovascular community.
Behind every study, discussion and innovation presented during EuroPCR remains a shared objective: improving patient care and patient outcomes through high-quality clinical research.
CERC would like to sincerely thank all investigators, study teams, partners and collaborators who contributed to making EuroPCR 2026 such a successful and inspiring congress.
We are already looking forward to the next edition in Paris, from 18–21 May 2027.
CERC. Smart trials. Strong results.
